National Center for Advancing Translational Sciences; Notice of Closed Meeting, 39444 [2017-17427]

Download as PDF 39444 Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices • Ease of manufacture • Efficient norovirus detection Development Stage • In vivo data available (animal) Inventors: Kim Green, Ph.D. (NIAID); Gabriel Parra, Ph.D. (NIAID); Stanislav Sosnovtsev, Ph.D. (NIAID); Karin Bok, Ph.D. (NIAID); Carlos Sandoval-Jaime, Ph.D. (NIAID); Eugenio Abente, Ph.D. (NIAID) Intellectual Property: HHS Reference No. E–101–2013/0. Licensing Contact: Peter Soukas, J.D., (301) 594–8730; peter.soukas@nih.gov. Collaborative Research Opportunity: The National Institute of Allergy and Infectious Diseases is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize norovirus diagnostics or vaccines. For collaboration opportunities, please contact Peter Soukas, J.D., (301) 594–8730; peter.soukas@nih.gov. Dated: August 3, 2017. Suzanne Frisbie, Deputy Director, Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases. [FR Doc. 2017–17438 Filed 8–17–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting mstockstill on DSK30JT082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel Contract Review. Date: September 12, 2017. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, One Democracy Plaza, Room 1037, 6701 VerDate Sep<11>2014 17:47 Aug 17, 2017 Jkt 241001 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing, Translational Sciences, 6701 Democracy Blvd., Rm 1078, Bethesda, MD 20892, 301– 894–7319, khanr2@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: August 14, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–17427 Filed 8–17–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; NIBIB Team-Based R25 Review (2018/01). Date: September 28, 2017. Time: 09:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building, Suite 957, Bethesda, MD 20892, (301) 496–4773, zhour@mail.nih.gov. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; T32–R25 Review Meeting (2018/01). Date: October 24, 2017. Time: 09:30 a.m. to 7:00 p.m. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John K. Hayes, Ph.D., Scientific Review Officer, 6707 Democracy Blvd., Suite 959, Democracy Two, Bethesda, MD 20892, (301) 451–3398, hayesj@ mail.nih.gov. Dated: August 14, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–17429 Filed 8–17–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services [OMB Control Number 1615–0120] Agency Information Collection Activities; Extension, Without Change, of a Currently Approved Collection; Free Training for Civics and Citizenship of Adults, Form G–1190; Civics and Citizenship Toolkit, Form G–1515 U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: 30-Day notice. AGENCY: The Department of Homeland Security (DHS), U.S. Citizenship and Immigration Services (USCIS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. The purpose of this notice is to allow an additional 30 days for public comments. DATES: The purpose of this notice is to allow an additional 30 days for public comments. Comments are encouraged and will be accepted until September 18, 2017. This process is conducted in accordance with 5 CFR 1320.10. ADDRESSES: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, must be directed to the OMB USCIS Desk Officer via email at dhsdeskofficer@ omb.eop.gov. All submissions received must include the agency name and the OMB Control Number 1615–0120 in the subject line. You may wish to consider limiting the amount of personal information that you SUMMARY: E:\FR\FM\18AUN1.SGM 18AUN1

Agencies

[Federal Register Volume 82, Number 159 (Friday, August 18, 2017)]
[Notices]
[Page 39444]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17427]



-----------------------------------------------------------------------



DEPARTMENT OF HEALTH AND HUMAN SERVICES



National Institutes of Health




National Center for Advancing Translational Sciences; Notice of 

Closed Meeting



    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 

amended, notice is hereby given of the following meeting.

    The meeting will be closed to the public in accordance with the 

provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 

U.S.C., as amended. The contract proposals and the discussions could 

disclose confidential trade secrets or commercial property such as 

patentable material, and personal information concerning individuals 

associated with the contract proposals, the disclosure of which would 

constitute a clearly unwarranted invasion of personal privacy.



    Name of Committee: National Center for Advancing Translational 

Sciences Special Emphasis Panel Contract Review.

    Date: September 12, 2017.

    Time: 1:00 p.m. to 4:00 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: National Institutes of Health, One Democracy Plaza, Room 

1037, 6701 Democracy Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call).

    Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review 

Officer, Office of Scientific Review, National Center for Advancing, 

Translational Sciences, 6701 Democracy Blvd., Rm 1078, Bethesda, MD 

20892, 301-894-7319, khanr2@csr.nih.gov.



(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 

Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 

B--Cooperative Agreements; 93.859, Biomedical Research and Research 

Training, National Institutes of Health, HHS)





    Dated: August 14, 2017.

David Clary,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2017-17427 Filed 8-17-17; 8:45 am]

BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.